🟢 Tscan Therapeutics is trading 7.9% up today as it rebounds amid broader market strength

Tscan Therapeutics is trading at $0.80 (7.9%) up today, rebounding from a multi-day downtrend amid an improving broader market risk tone.

• The pre-market strength appears linked to higher index futures rather than any company-specific news, earnings reports, or analyst updates.
• The stock is attempting to recover after a period of sustained weakness and a multi-day downward trend.